And this is the stepping stone for creating an effective antimicrobial drug.
Back in 2015, a team of scientists discovered a special antibiotic called teixobactin. Now a multinational team has for the first time succeeded in synthesizing compounds and used it to treat bacterial infections in mice. This is a milestone in the search for and developing a new drug to fight the antibiotic-resistant virus.
"When teixobactin was discovered, it evolved itself into a new antibiotic capable of destroying undetectable bacteria, including viruses like MRSA, but natural teixobactin did not work. for human beings, "explains the scientist involved in the study, Ishwar Singh.
At the end of last year, a team at Lincoln University said they had successfully developed a new synthetic version of teixobactin, with a simpler synthesis process that accelerated the process from more than 30 hours to less than full. 10 minutes. At that time, the efficacy of the drug was only demonstrated in vitro.
Now researchers from the Singapore Eye Research Institute have shown that the compound can successfully kill Staphylococcus aureus in test mice. This drug may also reduce the severity of serious infections in animals, which is surprising because the clinical substitution with moxifloxacin is not available.
"The fact that we succeeded in bringing the results from the laboratory to reality is a leapfrog in the development of new birth pills and has brought us closer to the hidden potential of teixobactin," Singh said. .
Teixobactin represents a new generation of antibiotics, the first generation that was isolated from bacteria 30 years ago. Since the discovery of teixobactin in 2015, scientists have come up with a new class of antibiotics called malacidins in early 2018. The finding is still in its early stages and there are still many more years to come. On our medical clinics.
"A significant amount of work remains to develop teixobactin into an antibiotic for human use, and it takes 6 to 10 years to produce a medication that doctors can prescribe for the patient. . But this is a big step forward, helping to open the door to improved drugs used in the body, "Singh said.
This study was published in the Journal of Medicinal Chemistry.
Back in 2015, a team of scientists discovered a special antibiotic called teixobactin. Now a multinational team has for the first time succeeded in synthesizing compounds and used it to treat bacterial infections in mice. This is a milestone in the search for and developing a new drug to fight the antibiotic-resistant virus.
"When teixobactin was discovered, it evolved itself into a new antibiotic capable of destroying undetectable bacteria, including viruses like MRSA, but natural teixobactin did not work. for human beings, "explains the scientist involved in the study, Ishwar Singh.
At the end of last year, a team at Lincoln University said they had successfully developed a new synthetic version of teixobactin, with a simpler synthesis process that accelerated the process from more than 30 hours to less than full. 10 minutes. At that time, the efficacy of the drug was only demonstrated in vitro.
Now researchers from the Singapore Eye Research Institute have shown that the compound can successfully kill Staphylococcus aureus in test mice. This drug may also reduce the severity of serious infections in animals, which is surprising because the clinical substitution with moxifloxacin is not available.
"The fact that we succeeded in bringing the results from the laboratory to reality is a leapfrog in the development of new birth pills and has brought us closer to the hidden potential of teixobactin," Singh said. .
Teixobactin represents a new generation of antibiotics, the first generation that was isolated from bacteria 30 years ago. Since the discovery of teixobactin in 2015, scientists have come up with a new class of antibiotics called malacidins in early 2018. The finding is still in its early stages and there are still many more years to come. On our medical clinics.
"A significant amount of work remains to develop teixobactin into an antibiotic for human use, and it takes 6 to 10 years to produce a medication that doctors can prescribe for the patient. . But this is a big step forward, helping to open the door to improved drugs used in the body, "Singh said.
This study was published in the Journal of Medicinal Chemistry.